The House Energy and Commerce Subcommittee on Health today held a hearing examining the increasing cost of prescription drugs in the Medicare program and ways to improve coverage and reduce costs for seniors. The hearing focused predominantly on Medicare Parts B and D.
 
Witness James Mathews, executive director for the Medicare Payment Advisory Commission, said the commission is concerned that “high prices for certain drugs make it difficult to ensure beneficiaries’ access to medications.”
 
House Energy and Commerce Committee Ranking Member Greg Walden, R-Ore., discussed the need to modernize Part B to keep patient out-of-pocket costs low and affordable.
 
“We have worked in a bipartisan manner on lowering drug costs over the last several years during my tenure as chairman of this committee, and during the first few months of this year we have continued those efforts,” Walden said. “So I believe that that should continue and this hearing will help us further our bipartisan work to lower drug costs for American consumers and seniors who rely upon Medicare.”
 
The AHA has offered a number of policy solutions to address the rising cost of prescription drugs. 
 

Related News Articles

Headline
The AHA Sept. 15 expressed support for the Ensuring Access to Essential Providers Act, legislation that would require Medicare Advantage plans to cover…
Headline
The AHA Sept. 15 urged Aetna to rescind its recently announced “level of severity inpatient payment” policy, saying that it “could erode the transparency…
Perspective
Public
Every health care provider strives to deliver their patients the best possible care, but not all providers offer the same level or complexity of care. Current…
Headline
A JAMA internal medicine study published Sept. 8 found that since the COVID-19 pandemic, Medicare Advantage beneficiaries have been experiencing longer…
Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…